Safety confirmation test by intake of food containing plant extract
- Conditions
- Healthy Japanese adult
- Registration Number
- JPRN-UMIN000036778
- Lead Sponsor
- Oneness support CO., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 22
Not provided
People with a history of liver, kidney, digestive system, heart disease, respiration, endocrine, metabolism, nerve, consciousness disorder, diabetes, seizures, and other diseases that may affect the results of this test, or Person who has a history of surgery. Patients who have been hospitalized for treatment due to stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, brain contusion, head injury. Those who show abnormal liver and kidney function test values. Person who has disease under treatment now. Person with food and drug allergy. Person with anemia symptom. Those who have experienced ill mood or worsened physical condition by blood collection in the past. Those who donated more than 200 mL from the month before the start of the test to the start of the test, or those who have plans for it during the test period. Those who do intense sports and those who are on a diet. Person who has excessive smoking habit. Those who have an irregular diet. Persons who regularly use health food (including antioxidants, supplements with blood flow improvement effect) for the purpose of improving brain function or forgetfulness. Those who are taking medicines (anti-psychotic, anxiety, depressants, Parkinson's disease, epilepsy, blood clotting drugs, etc.) that may affect this study. Persons who can not quit the intake of health food (including food for specified health and functional indication food) or designated quasi-drugs during the test period. Those who are taking medication (including OTC and prescription drugs) continuously. Those who have consumed too much alcohol or who can not drink alcohol from the day before the test until the day. persons who are pregnant or who are planning pregnancy or breastfeeding during the study period. Those who are participating in or planning to participate in other clinical trials at the beginning of this trial, within 4 weeks after the end of the trial. Others who are judged inappropriate by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physical hand and physical examination Hematology and blood biochemistry Urinalysis Journal
- Secondary Outcome Measures
Name Time Method